Emdactilin 150 56.7 mg/ml Oplossing voor injectie
Emdactilin 150 56.7 mg/ml Oplossing voor injectie
Authorised
- Lincomycin hydrochloride
- SPECTINOMYCIN HYDROCHLORIDE
Product identification
Medicine name:
Emdactilin 150 56.7 mg/ml Oplossing voor injectie
Emdactilin 150 56.7 mg/ml Solution injectable
Emdactilin 150 56.7 mg/ml Injektionslösung
Active substance:
- Lincomycin hydrochloride
- SPECTINOMYCIN HYDROCHLORIDE
Target species:
-
Pig
-
Cattle (calf)
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Lincomycin hydrochloride56.70/milligram(s)1.00millilitre(s)
-
SPECTINOMYCIN HYDROCHLORIDE149.01/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Pig
-
Meat and offal16day
-
- Cattle (calf)
-
Meat and offal24day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FF52
- QJ01XX04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- Emdactilin 150 12 Vials with 250 ml Solution for injection
- Emdactilin 150 6 Vials with 250 ml Solution for injection
- Emdactilin 150 1 Vial with 250 ml Solution for injection
- Emdactilin 150 12 Vials with 100 ml Solution for injection
- Emdactilin 150 6 Vials with 100 ml Solution for injection
- Emdactilin 150 1 Vial with 100 ml Solution for injection
- Emdactilin 150 12 Vials with 50 ml Solution for injection
- Emdactilin 150 6 Vials with 50 ml Solution for injection
- Emdactilin 150 1 Vial with 50 ml Solution for injection
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Emdoka
Marketing authorisation date:
Manufacturing sites for batch release:
- Produlab Pharma B.V.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V169102
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
How useful was this page?:
